CPEX Pharmaceuticals, Inc. CPEX today announced that its Board of Directors has completed its review of the unsolicited, non-binding letter received from Mangrove Partners on March 16, 2011 revising the terms of the potential alternative transaction involving a recapitalization of CPEX that Mangrove had originally proposed on March 14, 2011.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in